Is molecular testing in patients with low risk papillary thyroid carcinoma justified? A Markovian model

Gilad Feinmesser, Raphael Feinmesser, Eran E. Alon, Galit Avior, Moshe Leshno

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Is molecular testing in patients with low risk papillary thyroid carcinoma justified? A Markovian model'. Together they form a unique fingerprint.

Medicine & Life Sciences